Review of treatment strategies after lymphadenectomy: From molecular therapeutics to immediate microsurgical lymphatic reconstruction
- PMID: 38316291
- PMCID: PMC11523459
- DOI: 10.1016/j.jvsv.2024.101844
Review of treatment strategies after lymphadenectomy: From molecular therapeutics to immediate microsurgical lymphatic reconstruction
Abstract
Objective: Lymphedema is a common complication of cancer treatment, such as lymphadenectomy and radiation therapy. It is a debilitating condition with pathologic tissue changes that hinder effective curative treatment and jeopardize patients' quality of life. Various attempts to prevent the development of lymphedema have been made, with improvements in the incidence of the pathology. However, it is still prevalent among survivors of cancer. In this paper, we review both molecular therapeutics and immediate surgical lymphatic reconstruction as treatment strategies after lymphadenectomy. Specifically, we discuss pro-lymphangiogenic molecules that have proved efficient in animal models of lymphedema and clinical trials, and review currently available microsurgical techniques of immediate lymphatic reconstruction.
Methods: A literature search was conducted in PubMed, Embase, Cochrane Library, and Google Scholar through May 2022. Searches were done separately for molecular therapeutics and microsurgical techniques for immediate lymphatic reconstruction. Search terms used for (1) non-surgical methods include 'lymphangiogenesis,' 'lymphedema,' 'growth factor,' and 'gene therapy.' Search terms used for (2) surgical methods include 'lymphedema,' 'lymph node excision,' 'lymphatic vessels,' 'primary prevention,' and 'microsurgery.'
Results: Various pro-lymphangiogenic factors with therapeutic potential include VEGF-C, VEGF-D, HGF, bFGF, PDGF, IGF, Retinoic acid, Ang-1, S1P, TLR4, and IL-8. Microsurgical lymphatic reconstruction for prevention of secondary lymphedema includes lymphovenous anastomosis, vascularized lymph node flap transfer, and lymph-interpositional flap transfer, with promising clinical outcomes.
Conclusions: With growing knowledge of the lymphangiogenic pathway and lymphedema pathology and advances in microsurgical techniques to restore lymphatic channels, molecular and surgical approaches may represent a promising method for primary prevention of lymphedema.
Keywords: Immediate lymphatic reconstruction; Lymphangiogenesis; Lymphedema; Lymphovenous anastomosis.
Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosures Alex K. Wong is Founder of Lymphagen, Inc.
Figures
Similar articles
-
Supermicrosurgery lymphaticovenous and lymphaticolymphatic anastomosis: Technical detail and short-term follow-up for immediate lymphatic reconstruction in breast cancer treatment-related lymphedema prevention.J Vasc Surg Venous Lymphat Disord. 2024 Jul;12(4):101863. doi: 10.1016/j.jvsv.2024.101863. Epub 2024 Feb 28. J Vasc Surg Venous Lymphat Disord. 2024. PMID: 38428499 Free PMC article.
-
Immediate lymphatic reconstruction.J Surg Oncol. 2018 Oct;118(5):750-757. doi: 10.1002/jso.25177. Epub 2018 Aug 16. J Surg Oncol. 2018. PMID: 30114329 Review.
-
Experimental assessment of pro-lymphangiogenic growth factors in the treatment of post-surgical lymphedema following lymphadenectomy.Breast Cancer Res. 2010;12(5):R70. doi: 10.1186/bcr2638. Epub 2010 Sep 8. Breast Cancer Res. 2010. PMID: 20825671 Free PMC article.
-
Techniques and Outcomes in Microsurgical Treatment of Posttraumatic Lymphedema: A Systematic Review.J Reconstr Microsurg. 2024 Oct;40(8):635-641. doi: 10.1055/a-2257-5345. Epub 2024 Jan 30. J Reconstr Microsurg. 2024. PMID: 38290562
-
Reverse Lymphatic Mapping and Immediate Microsurgical Lymphatic Reconstruction Reduces Early Risk of Breast Cancer-Related Lymphedema.Plast Reconstr Surg. 2022 May 1;149(5):1061-1069. doi: 10.1097/PRS.0000000000008986. Epub 2022 Mar 7. Plast Reconstr Surg. 2022. PMID: 35255010
Cited by
-
Activation of lymphangiogenesis by platelet as novel therapeutic approaches for liver cirrhosis and portal hypertension.World J Gastroenterol. 2025 Jun 21;31(23):107554. doi: 10.3748/wjg.v31.i23.107554. World J Gastroenterol. 2025. PMID: 40575337 Free PMC article.
-
Tissue-Engineered Therapeutics for Lymphatic Regeneration: Solutions for Myocardial Infarction and Secondary Lymphedema.Adv Healthc Mater. 2025 Mar;14(6):e2403551. doi: 10.1002/adhm.202403551. Epub 2025 Jan 13. Adv Healthc Mater. 2025. PMID: 39806804 Review.
References
-
- Rockson S.G., Keeley V., Kilbreath S., Szuba A., Towers A. Cancer-associated secondary lymphoedema. Nat Rev Dis Primers. 2019;5:22. - PubMed
-
- Petrek J.A., Senie R.T., Peters M., Rosen P.P. American Cancer Society Journals: Cancer; 2001. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis; pp. 1368–1377. - PubMed
-
- DiSipio T., Rye S., Newman B., Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14:500–515. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous